心脏生物标志物 - 副本.ppt

BNP医保收费252元 Athough patients in the NT-proBNP arm ended the trial on higher doses of medications overall, the primary endpoint of mortality, depicted here, suggested that there was no significant difference between the clinical and NT-proBNP arms. Why might NT-proBNP guide therapy in the outpatient setting? As with acute heart failure, NT-proBNP concentrations are powerfully indicative of HF status and prognosis and are useful across the entire spectrum of HF stages. As with all other venues, serial testing is more powerful than a single measurement to identify risk. Why might NT-proBNP guid